Incremental health care resource utilization and costs associated among patients with Parkinson's disease psychosis and incident dementia: An analysis of medicare beneficiaries

Author:

Rajagopalan Krithika1,Rashid Nazia2,Gopal Daksha1,Doshi Dilesh2

Affiliation:

1. Anlitiks Inc. Orlando Florida USA

2. Acadia Pharmaceuticals San Diego California USA

Abstract

AbstractBackgroundReal‐world evidence examining the incremental health care resource use (HCRU) and cost burden of incident dementia among patients with Parkinson's disease psychosis (PDP) are needed within the United States (US).ObjectivesTo compare HCRU and cost burden between PDP patients with incident dementia (PDP + D) versus without incident dementia (PDP).MethodsA retrospective analysis of inpatient (Part A), outpatient (Part B), and prescription drug (Part D) claims from the 100% Medicare sample was conducted to compare PDP + D patients versus PDP patients between 01/01/14‐12/31/18. Patients with a diagnosis of dementia, psychosis, secondary parkinsonism, or other psychotic disorders, during 12‐month pre‐index were excluded. Patients in both groups were matched using 1:1 propensity score matching (PSM) methodology using 31 variables (age, sex, race, region and 27 Elixhauser comorbidity characteristics). Differences in 12‐month post‐index HCRU rates and mean per patient per year (PPPY) costs for all‐cause inpatient (IP) hospitalizations, and by type of IP stay (i.e., short‐term [ST‐stay], skilled nursing facility [SNF‐stay] and long‐term [LT‐stay]) were analyzed via logistic and gamma log‐link regression models.ResultsOf the 12,484 patients who met our study criteria, 1855 PSM‐matched cohorts were identified. Mean age, gender, and comorbidities were similar in PSM groups. Approximately, 50.3% with PDP + D reported ≥1 all‐cause IP hospitalizations versus 36.0% with PDP (p < 0.05) during 12‐month follow‐up. Specifically, all‐cause ST‐stay, SNF‐stay, and LT‐stay among PDP + D versus PDP patients were: 45.2% versus 35.7%, 28.3% versus 15.7%, and 8.5% versus 6.0% (p < 0.05), respectively. Psychiatric‐related ST‐stay, SNF‐stay, and LT‐stay among PDP + D versus PDP patients were: 12.3% versus 9.0%, 7.5% versus 3.4%, and 2.4% versus 1.2% (p < 0.05), respectively. Mean PPPY all‐cause IP hospitalization costs for PDP + D patients versus PDP patients was $17,891 (±29,882) versus $11,599 (±$25,247) (p < 0.05).ConclusionsPatients with PDP + D experience significantly higher all‐cause and psychiatric‐related IP hospitalizations, including ST‐stays, LT stays, and SNF stays. They also had 54% greater mean PPPY IP hospitalization costs versus PDP patients.

Funder

ACADIA Pharmaceuticals

Publisher

Wiley

Subject

Psychiatry and Mental health,Geriatrics and Gerontology

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3